LYEL
Lyell Immunopharma Inc.
$11.08
-$0.02(-0.18%)
58
Overall
--
Value
58
Tech
--
Quality
Market Cap
$210.55M
Volume
21.43K
52W Range
$7.65 - $32.00
Target Price
$11.00
EPS Estimates Overview
| Current Quarter | $-3.8 | Next Quarter | $-3.8 |
| Current Year | $-15.53 | Next Year | $-15.54 |
| QoQ Growth | +0.0% | YoY Growth | -0.1% |
| 3Y EPS CAGR | +56.6% | Target Price | $11.00 |
| Consensus | Buy | Upside | -0.7% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LYEL | $11.08 | -0.2% | 21.43K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |